Stanford
University
  • Stanford Home
  • Maps & Directions
  • Search Stanford
  • Emergency Info
  • Terms of Use
  • Privacy
  • Copyright
  • Trademarks
  • Non-Discrimination
  • Accessibility
© Stanford University.  Stanford, California 94305.
Smart Start—Designing Powerful Clinical Trials Using Pilot Study Data | Stanford HAI

Stay Up To Date

Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.

Sign Up For Latest News

Navigate
  • About
  • Events
  • Careers
  • Search
Participate
  • Get Involved
  • Support HAI
  • Contact Us
Skip to content
  • About

    • About
    • People
    • Get Involved with HAI
    • Support HAI
    • Subscribe to Email
  • Research

    • Research
    • Fellowship Programs
    • Grants
    • Student Affinity Groups
    • Centers & Labs
    • Research Publications
    • Research Partners
  • Education

    • Education
    • Executive and Professional Education
    • Government and Policymakers
    • K-12
    • Stanford Students
  • Policy

    • Policy
    • Policy Publications
    • Policymaker Education
    • Student Opportunities
  • AI Index

    • AI Index
    • AI Index Report
    • Global Vibrancy Tool
    • People
  • News
  • Events
  • Industry
  • Centers & Labs
research

Smart Start—Designing Powerful Clinical Trials Using Pilot Study Data

Date
January 22, 2024
Topics
Healthcare
Your browser does not support the video tag.
Read Paper
abstract

BACKGROUND

Digital health interventions may be optimized before evaluation in a randomized clinical trial. Although many digital health interventions are deployed in pilot studies, the data collected are rarely used to refine the intervention and the subsequent clinical trials.

METHODS

We leverage natural variation in patients eligible for a digital health intervention in a remote patient-monitoring pilot study to design and compare interventions for a subsequent randomized clinical trial.

RESULTS

Our approach leverages patient heterogeneity to identify an intervention with twice the estimated effect size of an unoptimized intervention.

CONCLUSIONS

Optimizing an intervention and clinical trial based on pilot data may improve efficacy and increase the probability of success. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT04336969.)

Share
Link copied to clipboard!
Authors
  • Johannes Ferstad
  • Priya Prahalad
    Priya Prahalad
  • Dessi P Zaharieva
  • Emily Fox
    Emily Fox
  • Manisha Desai
  • Ramesh Johari
    Ramesh Johari
  • David Scheinker
    David Scheinker
  • David Maahs
    David Maahs
Related
  • Active
    Hoffman-Yee Research Grants
    Open. Letters of Intent due on January 28, 2026.

    The Hoffman-Yee Research Grants are designed to address significant scientific, technical, or societal challenges requiring an interdisciplinary team and a bold approach.

    These grants are made possible by a gift from philanthropists Reid Hoffman and Michelle Yee.

Related Publications

The AI Arms Race In Health Insurance Utilization Review: Promises Of Efficiency And Risks Of Supercharged Flaws
Michelle Mello, Artem Trotsyuk, Abdoul Jalil Djiberou Mahamadou, Danton Char
Quick ReadJan 06, 2026
Research
Your browser does not support the video tag.

Health insurers and health care provider organizations are increasingly using artificial intelligence (AI) tools in prior authorization and claims processes. AI offers many potential benefits, but its adoption has raised concerns about the role of the “humans in the loop,” users’ understanding of AI, opacity of algorithmic determinations, underperformance in certain tasks, automation bias, and unintended social consequences. To date, institutional governance by insurers and providers has not fully met the challenge of ensuring responsible use. However, several steps could be taken to help realize the benefits of AI use while minimizing risks. Drawing on empirical work on AI use and our own ethical assessments of provider-facing tools as part of the AI governance process at Stanford Health Care, we examine why utilization review has attracted so much AI innovation and why it is challenging to ensure responsible use of AI. We conclude with several steps that could be taken to help realize the benefits of AI use while minimizing risks.

Research
Your browser does not support the video tag.

The AI Arms Race In Health Insurance Utilization Review: Promises Of Efficiency And Risks Of Supercharged Flaws

Michelle Mello, Artem Trotsyuk, Abdoul Jalil Djiberou Mahamadou, Danton Char
HealthcareRegulation, Policy, GovernanceQuick ReadJan 06

Health insurers and health care provider organizations are increasingly using artificial intelligence (AI) tools in prior authorization and claims processes. AI offers many potential benefits, but its adoption has raised concerns about the role of the “humans in the loop,” users’ understanding of AI, opacity of algorithmic determinations, underperformance in certain tasks, automation bias, and unintended social consequences. To date, institutional governance by insurers and providers has not fully met the challenge of ensuring responsible use. However, several steps could be taken to help realize the benefits of AI use while minimizing risks. Drawing on empirical work on AI use and our own ethical assessments of provider-facing tools as part of the AI governance process at Stanford Health Care, we examine why utilization review has attracted so much AI innovation and why it is challenging to ensure responsible use of AI. We conclude with several steps that could be taken to help realize the benefits of AI use while minimizing risks.

AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence
Tina Hernandez-Boussard, Michelle Mello, Nigam Shah, Co-authored by 50+ experts
Deep DiveOct 13, 2025
Research
Your browser does not support the video tag.
Research
Your browser does not support the video tag.

AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence

Tina Hernandez-Boussard, Michelle Mello, Nigam Shah, Co-authored by 50+ experts
HealthcareRegulation, Policy, GovernanceDeep DiveOct 13
Automated real-time assessment of intracranial hemorrhage detection AI using an ensembled monitoring model (EMM)
Zhongnan Fang, Andrew Johnston, Lina Cheuy, Hye Sun Na, Magdalini Paschali, Camila Gonzalez, Bonnie Armstrong, Arogya Koirala, Derrick Laurel, Andrew Walker Campion, Michael Iv, Akshay Chaudhari, David B. Larson
Deep DiveOct 13, 2025
Research
Your browser does not support the video tag.

Artificial intelligence (AI) tools for radiology are commonly unmonitored once deployed. The lack of real-time case-by-case assessments of AI prediction confidence requires users to independently distinguish between trustworthy and unreliable AI predictions, which increases cognitive burden, reduces productivity, and potentially leads to misdiagnoses. To address these challenges, we introduce Ensembled Monitoring Model (EMM), a framework inspired by clinical consensus practices using multiple expert reviews. Designed specifically for black-box commercial AI products, EMM operates independently without requiring access to internal AI components or intermediate outputs, while still providing robust confidence measurements. Using intracranial hemorrhage detection as our test case on a large, diverse dataset of 2919 studies, we demonstrate that EMM can successfully categorize confidence in the AI-generated prediction, suggest appropriate actions, and help physicians recognize low confidence scenarios, ultimately reducing cognitive burden. Importantly, we provide key technical considerations and best practices for successfully translating EMM into clinical settings.

Research
Your browser does not support the video tag.

Automated real-time assessment of intracranial hemorrhage detection AI using an ensembled monitoring model (EMM)

Zhongnan Fang, Andrew Johnston, Lina Cheuy, Hye Sun Na, Magdalini Paschali, Camila Gonzalez, Bonnie Armstrong, Arogya Koirala, Derrick Laurel, Andrew Walker Campion, Michael Iv, Akshay Chaudhari, David B. Larson
HealthcareRegulation, Policy, GovernanceDeep DiveOct 13

Artificial intelligence (AI) tools for radiology are commonly unmonitored once deployed. The lack of real-time case-by-case assessments of AI prediction confidence requires users to independently distinguish between trustworthy and unreliable AI predictions, which increases cognitive burden, reduces productivity, and potentially leads to misdiagnoses. To address these challenges, we introduce Ensembled Monitoring Model (EMM), a framework inspired by clinical consensus practices using multiple expert reviews. Designed specifically for black-box commercial AI products, EMM operates independently without requiring access to internal AI components or intermediate outputs, while still providing robust confidence measurements. Using intracranial hemorrhage detection as our test case on a large, diverse dataset of 2919 studies, we demonstrate that EMM can successfully categorize confidence in the AI-generated prediction, suggest appropriate actions, and help physicians recognize low confidence scenarios, ultimately reducing cognitive burden. Importantly, we provide key technical considerations and best practices for successfully translating EMM into clinical settings.

Developing mental health AI tools that improve care across different groups and contexts
Nicole Martinez-Martin
Deep DiveOct 10, 2025
Research
Your browser does not support the video tag.

In order to realize the potential of mental health AI applications to deliver improved care, a multipronged approach is needed, including representative AI datasets, research practices that reflect and anticipate potential sources of bias, stakeholder engagement, and equitable design practices.

Research
Your browser does not support the video tag.

Developing mental health AI tools that improve care across different groups and contexts

Nicole Martinez-Martin
HealthcareRegulation, Policy, GovernanceDeep DiveOct 10

In order to realize the potential of mental health AI applications to deliver improved care, a multipronged approach is needed, including representative AI datasets, research practices that reflect and anticipate potential sources of bias, stakeholder engagement, and equitable design practices.